首页 > 最新文献

Frontiers in Endocrinology最新文献

英文 中文
Macrovascular complications in type 2 diabetes: a multiregional study in rural Bangladesh. 2型糖尿病的大血管并发症:孟加拉国农村的一项多地区研究
IF 4.6 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2026-01-26 eCollection Date: 2026-01-01 DOI: 10.3389/fendo.2026.1724957
Bodrun Naher Siddiquea, Dianna J Magliano, Maima Matin, Afsana Afroz, Baki Billah

Objectives: To assess the prevalence and determinants of macrovascular complications (coronary artery disease, stroke, and diabetic foot) among adults living with T2DM in rural Bangladesh.

Methods: A population-based cross-sectional study was conducted between December 2023 and September 2024, involving 1094 adults with diagnosed T2DM from rural areas of three regions/divisions in Bangladesh. Data were collected through household interviews, physical examination, and medical record reviews. Macrovascular complications were identified using clinical criteria and documented diagnosis. The leverage of six machine learning (ML) algorithms were applied in identifying influential variables associated with these complications.

Results: The prevalence of coronary artery disease (CAD), stroke, and diabetic foot was 11.2%, 5.3%, and 9.1%, respectively. The Light Gradient Boosting Machine algorithm performed best for CAD and diabetic foot, with ROC values of 98.8% and 92.6%, respectively, while Random Forest showed the best performance for stroke with a ROC of 99%. These models also outperformed others across accuracy, precision, F1 score, and calibration. Across models, common predictors included older age, longer diabetes duration, diabetes onset at age 45 years or above, and smoking. Hypertension and elevated cholesterol were linked to CAD and stroke. Coexisting microvascular complications were also identified.

Conclusions: This study identified a substantial burden of macrovascular complications among rural adults with T2DM, with CAD, stroke, and diabetic foot emerging as the most prevalent outcomes. Advanced age, longer duration of diabetes, smoking, hypertension, and elevated cholesterol were consistently associated with these complications, highlighting the need for intensified cardiometabolic risk control within primary care. These findings underscore the urgency of strengthening integrated diabetes-cardiovascular management in rural Bangladesh to reduce the progression and impact of these major vascular outcomes.

目的:评估孟加拉国农村成年T2DM患者大血管并发症(冠状动脉疾病、中风和糖尿病足)的患病率和决定因素。方法:在2023年12月至2024年9月期间进行了一项基于人群的横断面研究,涉及孟加拉国三个地区/地区农村地区诊断为2型糖尿病的1094名成年人。通过家庭访谈、体格检查和医疗记录审查收集数据。根据临床标准和文献诊断确定大血管并发症。利用六种机器学习(ML)算法来识别与这些并发症相关的影响变量。结果:冠心病(CAD)患病率为11.2%,卒中患病率为5.3%,糖尿病足患病率为9.1%。Light Gradient Boosting Machine算法对CAD和糖尿病足表现最佳,ROC值分别为98.8%和92.6%,Random Forest算法对中风表现最佳,ROC值为99%。这些模型在准确性、精度、F1分数和校准方面也优于其他模型。在所有模型中,常见的预测因素包括年龄较大、糖尿病持续时间较长、45岁或以上的糖尿病发病以及吸烟。高血压和高胆固醇与冠心病和中风有关。同时也发现了并存的微血管并发症。结论:该研究确定了农村成年T2DM患者的大血管并发症负担,其中CAD、中风和糖尿病足是最常见的结局。高龄、糖尿病持续时间较长、吸烟、高血压和高胆固醇一直与这些并发症相关,这突出了在初级保健中加强心脏代谢风险控制的必要性。这些发现强调了在孟加拉国农村加强糖尿病-心血管综合管理的紧迫性,以减少这些主要血管结局的进展和影响。
{"title":"Macrovascular complications in type 2 diabetes: a multiregional study in rural Bangladesh.","authors":"Bodrun Naher Siddiquea, Dianna J Magliano, Maima Matin, Afsana Afroz, Baki Billah","doi":"10.3389/fendo.2026.1724957","DOIUrl":"10.3389/fendo.2026.1724957","url":null,"abstract":"<p><strong>Objectives: </strong>To assess the prevalence and determinants of macrovascular complications (coronary artery disease, stroke, and diabetic foot) among adults living with T2DM in rural Bangladesh.</p><p><strong>Methods: </strong>A population-based cross-sectional study was conducted between December 2023 and September 2024, involving 1094 adults with diagnosed T2DM from rural areas of three regions/divisions in Bangladesh. Data were collected through household interviews, physical examination, and medical record reviews. Macrovascular complications were identified using clinical criteria and documented diagnosis. The leverage of six machine learning (ML) algorithms were applied in identifying influential variables associated with these complications.</p><p><strong>Results: </strong>The prevalence of coronary artery disease (CAD), stroke, and diabetic foot was 11.2%, 5.3%, and 9.1%, respectively. The Light Gradient Boosting Machine algorithm performed best for CAD and diabetic foot, with ROC values of 98.8% and 92.6%, respectively, while Random Forest showed the best performance for stroke with a ROC of 99%. These models also outperformed others across accuracy, precision, F1 score, and calibration. Across models, common predictors included older age, longer diabetes duration, diabetes onset at age 45 years or above, and smoking. Hypertension and elevated cholesterol were linked to CAD and stroke. Coexisting microvascular complications were also identified.</p><p><strong>Conclusions: </strong>This study identified a substantial burden of macrovascular complications among rural adults with T2DM, with CAD, stroke, and diabetic foot emerging as the most prevalent outcomes. Advanced age, longer duration of diabetes, smoking, hypertension, and elevated cholesterol were consistently associated with these complications, highlighting the need for intensified cardiometabolic risk control within primary care. These findings underscore the urgency of strengthening integrated diabetes-cardiovascular management in rural Bangladesh to reduce the progression and impact of these major vascular outcomes.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"17 ","pages":"1724957"},"PeriodicalIF":4.6,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12883369/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146156627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How hypoxia-induced diabetes develops and is maintained in children born preterm. 低氧诱导的糖尿病是如何在早产儿童中发展和维持的。
IF 4.6 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2026-01-26 eCollection Date: 2025-01-01 DOI: 10.3389/fendo.2025.1720875
Eung-Kwon Pae, Ronald M Harper

A puzzling metabolic question is the emergence of rapid-onset diabetes in the postnatal period of pre-term infants without the usual preceding prodromal characteristics. The etio-pathophysiology is unclear, but continues to be a concern, since the prevalence remains a significant health issue. We hypothesize that this new diabetes type is hypoxemia-driven from compromised ventilation via periodic breathing or apnea of infancy during the immediate postnatal period. The resulting intermittent hypoxia leads to elevated cytosolic chloride levels in pancreatic beta-cells affecting insulin secretion and disturbed glucose transporter (GLUT) 4 function resulting from lowered With-no-lysine (k) kinase (WNK)1 levels in the skeletal musculature. In addition, the peripheral cellular effects are coupled with prolonged elevated sympathetic outflow elicited by the disrupted breathing. This mini-review discusses current research gaps and provides insights into potential interventions for the widespread epidemic of Type 1 and Type 2 diabetes.

一个令人困惑的代谢问题是在早产婴儿没有通常的前驱症状的产后出现快速发作的糖尿病。病因病理生理学尚不清楚,但仍是一个值得关注的问题,因为患病率仍然是一个重大的健康问题。我们假设这种新的糖尿病类型是由于婴儿在出生后的短时间内周期性呼吸或呼吸暂停导致的通气受损导致的低氧血症。由此产生的间歇性缺氧导致胰腺β细胞中胞质氯水平升高,影响胰岛素分泌和葡萄糖转运蛋白(GLUT) 4功能紊乱,导致骨骼肌中无赖氨酸激酶(k)激酶(WNK)1水平降低。此外,外周细胞效应与呼吸中断引起的交感神经外流延长升高相结合。这篇小型综述讨论了目前的研究空白,并提供了对1型和2型糖尿病广泛流行的潜在干预措施的见解。
{"title":"How hypoxia-induced diabetes develops and is maintained in children born preterm.","authors":"Eung-Kwon Pae, Ronald M Harper","doi":"10.3389/fendo.2025.1720875","DOIUrl":"10.3389/fendo.2025.1720875","url":null,"abstract":"<p><p>A puzzling metabolic question is the emergence of rapid-onset diabetes in the postnatal period of pre-term infants without the usual preceding prodromal characteristics. The etio-pathophysiology is unclear, but continues to be a concern, since the prevalence remains a significant health issue. We hypothesize that this new diabetes type is hypoxemia-driven from compromised ventilation <i>via</i> periodic breathing or apnea of infancy during the immediate postnatal period. The resulting intermittent hypoxia leads to elevated cytosolic chloride levels in pancreatic beta-cells affecting insulin secretion and disturbed glucose transporter (GLUT) 4 function resulting from lowered With-no-lysine (k) kinase (WNK)1 levels in the skeletal musculature. In addition, the peripheral cellular effects are coupled with prolonged elevated sympathetic outflow elicited by the disrupted breathing. This mini-review discusses current research gaps and provides insights into potential interventions for the widespread epidemic of Type 1 and Type 2 diabetes.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"16 ","pages":"1720875"},"PeriodicalIF":4.6,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12883372/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146156613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effects of combined endurance training of different intensities and resistance training on bone mineral density, microstructure and mechanical properties of rats. 不同强度耐力训练与阻力训练相结合对大鼠骨密度、显微结构及力学性能的影响。
IF 4.6 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2026-01-26 eCollection Date: 2026-01-01 DOI: 10.3389/fendo.2026.1716038
Ting Mo, Xin Zhang, Yueming Zhao, Guangxin Li, Zhanjia Zhang, Shilun Hou

Objective: To explore the effects of different intensities of endurance training combined with resistance training on the bones of growing male rats, and to provide the optimal exercise plan for bone mineral accumulation in adolescents.

Methods: Thirty 6-week-old male Sprague-Dawley rats were randomly divided into 5 groups: control (C), resistance training (R), low-intensity endurance + resistance (LR), moderate-intensity endurance + resistance (MR), and high-intensity interval + resistance (HR). After 8 weeks of exercise intervention, the bone mineral density, bone microstructure, bone mechanical properties and bone remodeling of rats were assessed. One-way analysis of variance (ANOVA) was used to test the results obtained by the detection methods.

Results: The body weight of the exercise group was lower than that of the control group. The endurance and resistance training group (LR/MR/HR) had significantly higher bone mineral density than the control group (p's < 0.05). There was no difference in bone metabolism markers among the groups. In the result of bone volume fraction, only the MR group was significantly higher than the control group (p = 0.03); the number of trabeculae showed statistical differences in the LR group and the MR group (p's < 0.05). Each exercise group showed significantly higher maximum load and fracture stress than the control group (p's ≤ 0.001), but no difference in maximum strain was shown.

Conclusion: Combined endurance and resistance training improved bone mineral density and mechanical strength in growing male rats, with moderate-intensity endurance training showing the most consistent improvements in bone microarchitecture.

目的:探讨不同强度耐力训练结合阻力训练对成年雄性大鼠骨骼发育的影响,为青少年骨矿物质积累提供最佳运动方案。方法:36周龄雄性Sprague-Dawley大鼠随机分为5组:对照组(C)、阻力训练组(R)、低强度耐力+阻力组(LR)、中强度耐力+阻力组(MR)、高强度间歇期+阻力组(HR)。运动干预8周后,观察大鼠骨密度、骨微结构、骨力学性能及骨重塑。采用单因素方差分析(ANOVA)对检测方法所得结果进行检验。结果:运动组体重明显低于对照组。耐力和阻力训练组(LR/MR/HR)骨密度显著高于对照组(p < 0.05)。各组间骨代谢指标无差异。在骨体积分数上,只有MR组显著高于对照组(p = 0.03);LR组与MR组小梁数目差异有统计学意义(p < 0.05)。各运动组的最大负荷和骨折应力均显著高于对照组(p < 0.001),但最大应变无显著差异。结论:耐力和阻力联合训练提高了生长中的雄性大鼠的骨矿物质密度和机械强度,中等强度耐力训练对骨微结构的改善最为一致。
{"title":"The effects of combined endurance training of different intensities and resistance training on bone mineral density, microstructure and mechanical properties of rats.","authors":"Ting Mo, Xin Zhang, Yueming Zhao, Guangxin Li, Zhanjia Zhang, Shilun Hou","doi":"10.3389/fendo.2026.1716038","DOIUrl":"10.3389/fendo.2026.1716038","url":null,"abstract":"<p><strong>Objective: </strong>To explore the effects of different intensities of endurance training combined with resistance training on the bones of growing male rats, and to provide the optimal exercise plan for bone mineral accumulation in adolescents.</p><p><strong>Methods: </strong>Thirty 6-week-old male Sprague-Dawley rats were randomly divided into 5 groups: control (C), resistance training (R), low-intensity endurance + resistance (LR), moderate-intensity endurance + resistance (MR), and high-intensity interval + resistance (HR). After 8 weeks of exercise intervention, the bone mineral density, bone microstructure, bone mechanical properties and bone remodeling of rats were assessed. One-way analysis of variance (ANOVA) was used to test the results obtained by the detection methods.</p><p><strong>Results: </strong>The body weight of the exercise group was lower than that of the control group. The endurance and resistance training group (LR/MR/HR) had significantly higher bone mineral density than the control group (<i>p</i>'s < 0.05). There was no difference in bone metabolism markers among the groups. In the result of bone volume fraction, only the MR group was significantly higher than the control group (<i>p</i> = 0.03); the number of trabeculae showed statistical differences in the LR group and the MR group (<i>p</i>'s < 0.05). Each exercise group showed significantly higher maximum load and fracture stress than the control group (<i>p</i>'s ≤ 0.001), but no difference in maximum strain was shown.</p><p><strong>Conclusion: </strong>Combined endurance and resistance training improved bone mineral density and mechanical strength in growing male rats, with moderate-intensity endurance training showing the most consistent improvements in bone microarchitecture.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"17 ","pages":"1716038"},"PeriodicalIF":4.6,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12883395/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146156541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical utility of anthropometric parameters in identifying glucose dysregulation in women with polycystic ovary syndrome. 人体测量参数在识别多囊卵巢综合征女性血糖失调中的临床应用。
IF 4.6 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2026-01-26 eCollection Date: 2025-01-01 DOI: 10.3389/fendo.2025.1756679
Justyna Nowak, Marzena Jabczyk, Jakub Borszcz, Paweł Jagielski, Barbara Zubelewicz-Szkodzińska

Background: Polycystic ovary syndrome (PCOS) is a common endocrine disorder often associated with disturbances in glucose metabolism and insulin resistance (IR), increasing the risk of type 2 diabetes (T2DM). Standard assessment of glucose dysregulations and IR requires laboratory tests, but simple anthropometric indices, including BMI, WHtR, WHR, VAI, LAP, BAI, BRI and ABSI, may provide non-invasive tools for early risk screening. Their predictive value and optimal cut-off points for detecting glucose dysregulation and IR in PCOS remain unclear.

Objectives: This study aims to evaluate the clinical utility of anthropometric indices in identifying glucose dysregulation in women with PCOS, and to provide prognostic insight with potential cut-off points for these indices.

Methods: This cross-sectional study included 49 women with PCOS according to Rotterdam criteria. Anthropometric measurements (BMI, WC, WHR, WHtR, VAI, BAI, LAP, BRI, ABSI) and fasting biochemical parameters (glucose, insulin) were collected. Correlations between indices and carbohydrate disturbances were assessed using Pearson or Spearman coefficients. The predictive ability of anthropometric indices for glucose dysregulations and IR were evaluated using ROC curve analysis, including AUC, sensitivity, specificity, and optimal cut-off points, while logistic regression quantified the strength of associations.

Results: BMI, WHtR, BAI, VAI, LAP, and BRI were significantly correlated with fasting glucose and insulin levels, indicating a strong link between adiposity and IR in women with PCOS. Among these indices, VAI showed the highest predictive performance for elevated HOMA-IR (AUC = 0.933, cut-off point 0.99; sensitivity 85.7, specificity 90.5%), followed by LAP (AUC = 0.883, cut-off point 27.9) and BMI (AUC = 0.852, cut off point 27 kg/m2). WHtR, WC, and BRI also demonstrated significant predictive value (AUCs 0.821-0.831). Logistic regression revealed the strongest associations for BMI ≥27.25 kg/m2 and VAI ≥1.07 (OR = 57.0; 95% CI 9.41-345.15; p<0.001), with WC, WHtR, LAP, BAI, and BRI also showed significant predictive value for IR.

Conclusion: Anthropometric indices, particularly VAI, LAP, and BMI, reliably predicts glucose dysregulations and IR in women with PCOS. These simple, non-invasive measurements may serve as useful screening tools for early identifications of glucose dysregulation, aiding risk stratification and guiding further metabolic assessment.

背景:多囊卵巢综合征(PCOS)是一种常见的内分泌紊乱,常伴有糖代谢紊乱和胰岛素抵抗(IR),增加2型糖尿病(T2DM)的风险。血糖失调和IR的标准评估需要实验室测试,但简单的人体测量指标,包括BMI、WHtR、WHR、VAI、LAP、BAI、BRI和ABSI,可能为早期风险筛查提供无创工具。它们在多囊卵巢综合征中检测葡萄糖失调和IR的预测价值和最佳截止点尚不清楚。目的:本研究旨在评估人体测量指标在识别多囊卵巢综合征女性血糖失调中的临床应用,并为这些指标的潜在截止点提供预后见解。方法:本横断面研究纳入49例多囊卵巢综合征患者,符合鹿特丹标准。收集人体测量数据(BMI、WC、WHR、WHtR、VAI、BAI、LAP、BRI、ABSI)和空腹生化参数(葡萄糖、胰岛素)。使用Pearson或Spearman系数评估指数与碳水化合物干扰之间的相关性。使用ROC曲线分析评估人体测量指标对血糖失调和IR的预测能力,包括AUC、敏感性、特异性和最佳截止点,而逻辑回归量化了相关性的强度。结果:BMI、WHtR、BAI、VAI、LAP和BRI与空腹血糖和胰岛素水平显著相关,表明PCOS女性肥胖与IR之间存在密切联系。其中,VAI对HOMA-IR升高的预测效果最高(AUC = 0.933,截断点0.99;敏感性85.7,特异性90.5%),其次是LAP (AUC = 0.883,截断点27.9)和BMI (AUC = 0.852,截断点27 kg/m2)。WHtR、WC和BRI也具有显著的预测价值(auc为0.821-0.831)。Logistic回归显示BMI≥27.25 kg/m2与VAI≥1.07相关性最强(OR = 57.0; 95% CI 9.41-345.15)。结论:人体测量指标,尤其是VAI、LAP和BMI可可靠预测PCOS女性的血糖失调和IR。这些简单、无创的测量可以作为早期识别葡萄糖失调的有用筛选工具,帮助风险分层和指导进一步的代谢评估。
{"title":"Clinical utility of anthropometric parameters in identifying glucose dysregulation in women with polycystic ovary syndrome.","authors":"Justyna Nowak, Marzena Jabczyk, Jakub Borszcz, Paweł Jagielski, Barbara Zubelewicz-Szkodzińska","doi":"10.3389/fendo.2025.1756679","DOIUrl":"10.3389/fendo.2025.1756679","url":null,"abstract":"<p><strong>Background: </strong>Polycystic ovary syndrome (PCOS) is a common endocrine disorder often associated with disturbances in glucose metabolism and insulin resistance (IR), increasing the risk of type 2 diabetes (T2DM). Standard assessment of glucose dysregulations and IR requires laboratory tests, but simple anthropometric indices, including BMI, WHtR, WHR, VAI, LAP, BAI, BRI and ABSI, may provide non-invasive tools for early risk screening. Their predictive value and optimal cut-off points for detecting glucose dysregulation and IR in PCOS remain unclear.</p><p><strong>Objectives: </strong>This study aims to evaluate the clinical utility of anthropometric indices in identifying glucose dysregulation in women with PCOS, and to provide prognostic insight with potential cut-off points for these indices.</p><p><strong>Methods: </strong>This cross-sectional study included 49 women with PCOS according to Rotterdam criteria. Anthropometric measurements (BMI, WC, WHR, WHtR, VAI, BAI, LAP, BRI, ABSI) and fasting biochemical parameters (glucose, insulin) were collected. Correlations between indices and carbohydrate disturbances were assessed using Pearson or Spearman coefficients. The predictive ability of anthropometric indices for glucose dysregulations and IR were evaluated using ROC curve analysis, including AUC, sensitivity, specificity, and optimal cut-off points, while logistic regression quantified the strength of associations.</p><p><strong>Results: </strong>BMI, WHtR, BAI, VAI, LAP, and BRI were significantly correlated with fasting glucose and insulin levels, indicating a strong link between adiposity and IR in women with PCOS. Among these indices, VAI showed the highest predictive performance for elevated HOMA-IR (AUC = 0.933, cut-off point 0.99; sensitivity 85.7, specificity 90.5%), followed by LAP (AUC = 0.883, cut-off point 27.9) and BMI (AUC = 0.852, cut off point 27 kg/m<sup>2</sup>). WHtR, WC, and BRI also demonstrated significant predictive value (AUCs 0.821-0.831). Logistic regression revealed the strongest associations for BMI ≥27.25 kg/m<sup>2</sup> and VAI ≥1.07 (OR = 57.0; 95% CI 9.41-345.15; p<0.001), with WC, WHtR, LAP, BAI, and BRI also showed significant predictive value for IR.</p><p><strong>Conclusion: </strong>Anthropometric indices, particularly VAI, LAP, and BMI, reliably predicts glucose dysregulations and IR in women with PCOS. These simple, non-invasive measurements may serve as useful screening tools for early identifications of glucose dysregulation, aiding risk stratification and guiding further metabolic assessment.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"16 ","pages":"1756679"},"PeriodicalIF":4.6,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12883394/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146156548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management strategies for isolated premature thelarche: a risk-stratified clinical pathway favoring "watchful waiting". 孤立性早发性关节炎的治疗策略:一种倾向于“观察等待”的风险分层临床途径。
IF 4.6 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2026-01-26 eCollection Date: 2025-01-01 DOI: 10.3389/fendo.2025.1705194
Yan Xu, Hongtao Cui, Xinna Wang, Fang Liu

Isolated Premature Thelarche (PT) is a common clinical issue in pediatric endocrinology. Because its early presentation resembles that of Central Precocious Puberty (CPP), which requires intervention, its management is highly controversial, caught between "active intervention" and "watchful waiting." This leads to inconsistent clinical practices and significant anxiety for affected families. This review aims to move beyond this traditional dichotomy by conducting an in-depth analysis of the natural history, pathophysiological mechanisms, diagnostic criteria, and progression risks of PT. We propose a new paradigm for a tiered, individualized management approach based on risk stratification, providing a clear, evidence-based pathway for clinical decision-making. Through a comprehensive review of recent clinical studies, reviews, and expert consensus, this paper analyzes the theoretical basis and evidence supporting a "watchful waiting" strategy. It defines the rigorous initial evaluation and dynamic monitoring protocols required for its implementation and clarifies the quantitative indicators for transitioning from "observation" to "active intervention." For children with typical PT-characterized by a normal growth rate, no significant bone age advancement, a prepubertal pelvic ultrasound, and a very low basal luteinizing hormone level-"watchful waiting" or "active surveillance" is a safe, effective, and preferred management strategy. This is an active medical monitoring process, not passive waiting. "Active intervention" (i.e., Gonadotropin-Releasing Hormone agonist therapy) should be strictly limited to the few "progressive" cases that show sustained pubertal progression, growth acceleration, and significant bone age advancement during follow-up, and are confirmed as CPP by a Gonadotropin-Releasing Hormone stimulation test. The risk-stratified management pathway proposed herein aims to effectively address the clinical dilemma, avoid over-treatment, and achieve individualized, precise management for children with PT.

孤立性早产儿(PT)是儿科内分泌学中常见的临床问题。由于其早期表现与需要干预的中枢性性早熟(CPP)相似,因此其管理争议很大,处于“积极干预”和“观察等待”之间。这导致了不一致的临床实践和受影响家庭的显著焦虑。这篇综述旨在通过深入分析PT的自然史、病理生理机制、诊断标准和进展风险来超越这种传统的二分法。我们提出了一种基于风险分层的分层、个性化管理方法的新范式,为临床决策提供了一个明确的、基于证据的途径。通过对近期临床研究、综述和专家共识的综合回顾,本文分析了支持“观察等待”策略的理论基础和证据。它定义了实施所需的严格的初步评估和动态监测方案,并阐明了从“观察”过渡到“积极干预”的量化指标。对于典型的pt患儿,其特征是生长速度正常,没有明显的骨龄进展,青春期前盆腔超声检查,基础黄体生成素水平很低,“观察等待”或“主动监测”是一种安全、有效和首选的治疗策略。这是一个主动的医疗监测过程,而不是被动的等待。“主动干预”(即促性腺激素释放激素激动剂治疗)应严格限于少数“进行性”病例,这些病例在随访中表现出持续的青春期发育、生长加速和明显的骨龄提前,并通过促性腺激素释放激素刺激试验证实为CPP。本文提出的风险分层管理路径旨在有效解决临床困境,避免过度治疗,实现PT患儿的个体化、精准化管理。
{"title":"Management strategies for isolated premature thelarche: a risk-stratified clinical pathway favoring \"watchful waiting\".","authors":"Yan Xu, Hongtao Cui, Xinna Wang, Fang Liu","doi":"10.3389/fendo.2025.1705194","DOIUrl":"10.3389/fendo.2025.1705194","url":null,"abstract":"<p><p>Isolated Premature Thelarche (PT) is a common clinical issue in pediatric endocrinology. Because its early presentation resembles that of Central Precocious Puberty (CPP), which requires intervention, its management is highly controversial, caught between \"active intervention\" and \"watchful waiting.\" This leads to inconsistent clinical practices and significant anxiety for affected families. This review aims to move beyond this traditional dichotomy by conducting an in-depth analysis of the natural history, pathophysiological mechanisms, diagnostic criteria, and progression risks of PT. We propose a new paradigm for a tiered, individualized management approach based on risk stratification, providing a clear, evidence-based pathway for clinical decision-making. Through a comprehensive review of recent clinical studies, reviews, and expert consensus, this paper analyzes the theoretical basis and evidence supporting a \"watchful waiting\" strategy. It defines the rigorous initial evaluation and dynamic monitoring protocols required for its implementation and clarifies the quantitative indicators for transitioning from \"observation\" to \"active intervention.\" For children with typical PT-characterized by a normal growth rate, no significant bone age advancement, a prepubertal pelvic ultrasound, and a very low basal luteinizing hormone level-\"watchful waiting\" or \"active surveillance\" is a safe, effective, and preferred management strategy. This is an active medical monitoring process, not passive waiting. \"Active intervention\" (i.e., Gonadotropin-Releasing Hormone agonist therapy) should be strictly limited to the few \"progressive\" cases that show sustained pubertal progression, growth acceleration, and significant bone age advancement during follow-up, and are confirmed as CPP by a Gonadotropin-Releasing Hormone stimulation test. The risk-stratified management pathway proposed herein aims to effectively address the clinical dilemma, avoid over-treatment, and achieve individualized, precise management for children with PT.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"16 ","pages":"1705194"},"PeriodicalIF":4.6,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12883376/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146156582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A meta-analysis of serum uric acid and diabetic nephropathy risk in type 2 diabetes. 2型糖尿病患者血清尿酸与糖尿病肾病风险的meta分析
IF 4.6 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2026-01-26 eCollection Date: 2025-01-01 DOI: 10.3389/fendo.2025.1651446
Jing Zhao, Lingzhu Zhao

Objective: To explore the correlation between serum uric acid (SUA) levels and the risk of diabetic kidney disease (DKD) in patients with type 2 diabetes mellitus (T2DM), and to evaluate the potential clinical implications of uric acid-lowering interventions.

Methods: Relevant studies on the relationship between serum uric acid levels and the risk of DKD in patients with type 2 diabetes mellitus were collected by systematically searching databases such as PubMed, Web of Science, and Cochrane Library. The quality of the included studies was evaluated using the Cochrane risk-of-bias assessment tool, and Meta-analysis was performed using RevMan 5.3 software. The primary outcome indicators included the incidence of DKD, the odds ratio (OR) and 95% confidence interval (CI) of the relationship between serum uric acid levels and the risk of DKD.

Results: After retrieval and screening, 8 randomized controlled trials (RCTs) (with a sample size of 491) were included in the Meta-analysis. The results showed that the estimated glomerular filtration rate (eGFR) in the hyperuricemia group was lower than that in the normal group (MD = 4.40, 95% CI [0.66, 8.14], P = 0.02), with low heterogeneity; the risk of DKD was significantly increased (OR = 1.85, 95% CI [1.52, 2.26], P<0.001), with moderate heterogeneity (I²=49%). Sensitivity analyses confirmed the robustness of these findings, though the limited sample size and moderate heterogeneity suggest caution in generalizing the results.

Conclusion: Elevated serum uric acid levels are significantly associated with an increased risk of DKD in patients with type 2 diabetes mellitus. Monitoring serum uric acid levels may help to identify high-risk individuals for DKD at an early stage and provide a reference for clinical intervention.

目的:探讨2型糖尿病(T2DM)患者血清尿酸(SUA)水平与糖尿病肾病(DKD)风险的相关性,并评价降尿酸干预的潜在临床意义。方法:系统检索PubMed、Web of Science、Cochrane Library等数据库,收集2型糖尿病患者血清尿酸水平与DKD风险关系的相关研究。采用Cochrane偏倚风险评估工具评价纳入研究的质量,采用RevMan 5.3软件进行meta分析。主要结局指标包括DKD发生率、血尿酸水平与DKD风险关系的比值比(OR)和95%可信区间(CI)。结果:经检索筛选,meta分析共纳入8项随机对照试验(RCTs),样本量491例。结果显示:高尿酸血症组肾小球滤过率(eGFR)估测值低于正常组(MD = 4.40, 95% CI [0.66, 8.14], P = 0.02),异质性较低;结论:血清尿酸水平升高与2型糖尿病患者DKD风险增加显著相关。监测血清尿酸水平有助于早期识别DKD高危人群,为临床干预提供参考。
{"title":"A meta-analysis of serum uric acid and diabetic nephropathy risk in type 2 diabetes.","authors":"Jing Zhao, Lingzhu Zhao","doi":"10.3389/fendo.2025.1651446","DOIUrl":"10.3389/fendo.2025.1651446","url":null,"abstract":"<p><strong>Objective: </strong>To explore the correlation between serum uric acid (SUA) levels and the risk of diabetic kidney disease (DKD) in patients with type 2 diabetes mellitus (T2DM), and to evaluate the potential clinical implications of uric acid-lowering interventions.</p><p><strong>Methods: </strong>Relevant studies on the relationship between serum uric acid levels and the risk of DKD in patients with type 2 diabetes mellitus were collected by systematically searching databases such as PubMed, Web of Science, and Cochrane Library. The quality of the included studies was evaluated using the Cochrane risk-of-bias assessment tool, and Meta-analysis was performed using RevMan 5.3 software. The primary outcome indicators included the incidence of DKD, the odds ratio (OR) and 95% confidence interval (CI) of the relationship between serum uric acid levels and the risk of DKD.</p><p><strong>Results: </strong>After retrieval and screening, 8 randomized controlled trials (RCTs) (with a sample size of 491) were included in the Meta-analysis. The results showed that the estimated glomerular filtration rate (eGFR) in the hyperuricemia group was lower than that in the normal group (MD = 4.40, 95% CI [0.66, 8.14], <i>P</i> = 0.02), with low heterogeneity; the risk of DKD was significantly increased (OR = 1.85, 95% CI [1.52, 2.26], <i>P</i><0.001), with moderate heterogeneity (I²=49%). Sensitivity analyses confirmed the robustness of these findings, though the limited sample size and moderate heterogeneity suggest caution in generalizing the results.</p><p><strong>Conclusion: </strong>Elevated serum uric acid levels are significantly associated with an increased risk of DKD in patients with type 2 diabetes mellitus. Monitoring serum uric acid levels may help to identify high-risk individuals for DKD at an early stage and provide a reference for clinical intervention.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"16 ","pages":"1651446"},"PeriodicalIF":4.6,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12883379/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146156569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Age rather than diabetes duration predicts the severity of sensory neuropathy in type 2 diabetes mellitus. 预测2型糖尿病感觉神经病变严重程度的是年龄而不是糖尿病病程。
IF 4.6 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2026-01-23 eCollection Date: 2025-01-01 DOI: 10.3389/fendo.2025.1763487
Áron T Kiss, Árpád Kézdi, Magdolna Békeffy, Csaba G Koós, Anna E Körei, Adrienn Menyhárt, Dóra M Balogh, Péter Kempler, Ádám Gy Tabák, Viktor J Horváth

Introduction: In patients with type 2 diabetes, factors beyond hyperglycemia may contribute to the development of sensory neuropathy. This study aimed to determine whether diabetes duration was the strongest predictor of prevalent sensory neuropathy and to compare the diagnostic performance of commonly used clinical screening methods.

Materials and methods: A total of 711 patients with type 2 diabetes from the Budapest metropolitan area were assessed between 2016 and 2022 using routine sensory neuropathy screening tests (128-Hz tuning fork and 10-g monofilament). A brief standardized questionnaire was also administered to support neuropathy detection. Independent predictors of sensory neuropathy were identified using binary logistic regression models and interrater agreement between diagnostic methods was assessed with Cohen's kappa.

Results: Agreement between diagnostic methods was only moderate (Cohen's kappa: 0.3-0.4). In the final adjusted models, age emerged as the only independent predictor of neuropathy detected by tuning fork testing (OR 1.04; 95% CI 1.02-1.06), whereas for the monofilament test, self-reported neuropathic symptoms remained independently associated. Consistent with this, positive responses to standardized symptom questions correlated with both diagnostic tests, supporting their clinical validity.

Conclusion: The overlap between routinely applied clinical methods for detecting sensory neuropathy is limited. Our findings suggest that, in an aging population with type 2 diabetes, peripheral nerve damage identified by standard screening tools is more strongly associated with age than with diabetes duration when assessed by commonly used bedside screening tools. Prospective studies are warranted to better differentiate diabetic neuropathy from age-related nerve dysfunction.

在2型糖尿病患者中,高血糖以外的因素可能有助于感觉神经病变的发展。本研究旨在确定糖尿病病程是否是普遍感觉神经病变的最强预测因子,并比较常用临床筛查方法的诊断效果。材料和方法:采用常规感觉神经病变筛查试验(128-Hz音叉和10-g单丝)对2016年至2022年间来自布达佩斯大都市区的711例2型糖尿病患者进行评估。一份简短的标准化问卷也被用于支持神经病变的检测。使用二元逻辑回归模型确定感觉神经病变的独立预测因子,并使用Cohen's kappa评估诊断方法之间的相互一致性。结果:两种诊断方法的一致性仅为中等(Cohen’s kappa: 0.3-0.4)。在最终调整的模型中,年龄成为音叉测试检测到的神经病变的唯一独立预测因子(OR 1.04; 95% CI 1.02-1.06),而对于单丝测试,自我报告的神经病变症状仍然独立相关。与此一致的是,对标准化症状问题的积极反应与两种诊断测试相关,支持其临床有效性。结论:常规临床感觉神经病变检测方法的重叠是有限的。我们的研究结果表明,在老年2型糖尿病患者中,当使用常用的床边筛查工具评估时,通过标准筛查工具确定的周围神经损伤与年龄的相关性比与糖尿病病程的相关性更强。前瞻性研究是必要的,以更好地区分糖尿病神经病变与年龄相关的神经功能障碍。
{"title":"Age rather than diabetes duration predicts the severity of sensory neuropathy in type 2 diabetes mellitus.","authors":"Áron T Kiss, Árpád Kézdi, Magdolna Békeffy, Csaba G Koós, Anna E Körei, Adrienn Menyhárt, Dóra M Balogh, Péter Kempler, Ádám Gy Tabák, Viktor J Horváth","doi":"10.3389/fendo.2025.1763487","DOIUrl":"10.3389/fendo.2025.1763487","url":null,"abstract":"<p><strong>Introduction: </strong>In patients with type 2 diabetes, factors beyond hyperglycemia may contribute to the development of sensory neuropathy. This study aimed to determine whether diabetes duration was the strongest predictor of prevalent sensory neuropathy and to compare the diagnostic performance of commonly used clinical screening methods.</p><p><strong>Materials and methods: </strong>A total of 711 patients with type 2 diabetes from the Budapest metropolitan area were assessed between 2016 and 2022 using routine sensory neuropathy screening tests (128-Hz tuning fork and 10-g monofilament). A brief standardized questionnaire was also administered to support neuropathy detection. Independent predictors of sensory neuropathy were identified using binary logistic regression models and interrater agreement between diagnostic methods was assessed with Cohen's kappa.</p><p><strong>Results: </strong>Agreement between diagnostic methods was only moderate (Cohen's kappa: 0.3-0.4). In the final adjusted models, age emerged as the only independent predictor of neuropathy detected by tuning fork testing (OR 1.04; 95% CI 1.02-1.06), whereas for the monofilament test, self-reported neuropathic symptoms remained independently associated. Consistent with this, positive responses to standardized symptom questions correlated with both diagnostic tests, supporting their clinical validity.</p><p><strong>Conclusion: </strong>The overlap between routinely applied clinical methods for detecting sensory neuropathy is limited. Our findings suggest that, in an aging population with type 2 diabetes, peripheral nerve damage identified by standard screening tools is more strongly associated with age than with diabetes duration when assessed by commonly used bedside screening tools. Prospective studies are warranted to better differentiate diabetic neuropathy from age-related nerve dysfunction.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"16 ","pages":"1763487"},"PeriodicalIF":4.6,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12875899/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146141077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating cardiac echocardiographic changes with levothyroxine in hypothyroid patients: a systematic review and meta-analysis. 评价甲状腺功能减退患者左旋甲状腺素的心脏超声心动图变化:一项系统回顾和荟萃分析。
IF 4.6 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2026-01-23 eCollection Date: 2025-01-01 DOI: 10.3389/fendo.2025.1708811
Yanyan Li

Background: While levothyroxine (L-T4) therapy is standard for hypothyroidism, its direct effects on specific echocardiographic parameters of cardiac function remain underexplored in comprehensive meta-analyses.

Methods: We systematically searched multiple databases up to June 2025 for randomized controlled trials and prospective cohort studies assessing L-T4 therapy on echocardiographic parameters in hypothyroid adults. Data on cardiac indices, intervention details, follow-up, and disease types were extracted. Risk of bias was assessed using standard tools. A random-effects model calculated mean differences (MDs) and assessed heterogeneity. Subgroup analyses evaluated treatment type, follow-up duration, and underlying disease.

Results: Six studies (2 RCTs and 4 cohort studies) were included. Overall, L-T4 intervention did not significantly alter the LV Tei Index (MD = 0.0214, 95% CI: -0.0294 to 0.0722, p=0.4083) or LVEF (MD = -0.2258, 95% CI: -0.8990 to 0.4475, p=0.5110). However, a statistically significant increase in Mitral E velocity (MD = -0.0646, 95% CI: -0.1138 to -0.0154, p=0.0100) and Mitral A velocity (MD = -0.0646, 95% CI: -0.1138 to -0.0154, p=0.0100) was observed. Subgroup analyses for LV Tei Index showed a statistically significant improvement in the 12-month follow-up subgroup (MD = 0.0672, 95% CI: 0.0161 to 0.1183) and in congenital hypothyroidism (MD = 0.0300, 95% CI: 0.0044 to 0.0556). For LVEF, a statistically significant increase was found in the 12-week follow-up subgroup (MD = -7.9300, 95% CI: -14.4844 to -1.3756) and the overt hypothyroidism subgroup (MD = -7.9300, 95% CI: -14.4844 to -1.3756). The effect of L-T4 on Mitral E and Mitral A velocities varied significantly across disease types (p=0.0304 for both), with a significant increase noted in the congenital hypothyroidism subgroup for both. No significant change was observed in the E/A ratio (MD = -0.0058, 95% CI: -0.0360 to 0.0244, p=0.7058), with no significant subgroup differences.

Conclusion: L-T4 exerts differential effects on echocardiographic measures of cardiac function, with specific improvements influenced by follow-up duration and underlying etiology.

Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/, CRD420251274519.

背景:虽然左旋甲状腺素(L-T4)治疗是甲状腺功能减退的标准治疗,但其对心功能特定超声心动图参数的直接影响在综合荟萃分析中仍未得到充分探讨。方法:我们系统地检索了截至2025年6月的多个数据库,以评估L-T4治疗对甲状腺功能低下成人超声心动图参数的随机对照试验和前瞻性队列研究。提取心脏指标、干预细节、随访和疾病类型的数据。使用标准工具评估偏倚风险。随机效应模型计算平均差异(MDs)并评估异质性。亚组分析评估治疗类型、随访时间和潜在疾病。结果:纳入6项研究(2项随机对照试验和4项队列研究)。总体而言,L-T4干预没有显著改变LV Tei指数(MD = 0.0214, 95% CI: -0.0294至0.0722,p=0.4083)或LVEF (MD = -0.2258, 95% CI: -0.8990至0.4475,p=0.5110)。然而,观察到二尖瓣E流速(MD = -0.0646, 95% CI: -0.1138 ~ -0.0154, p=0.0100)和二尖瓣a流速(MD = -0.0646, 95% CI: -0.1138 ~ -0.0154, p=0.0100)有统计学意义的增加。LV Tei指数的亚组分析显示,随访12个月的亚组(MD = 0.0672, 95% CI: 0.0161 ~ 0.1183)和先天性甲状腺功能减退(MD = 0.0300, 95% CI: 0.0044 ~ 0.0556)改善有统计学意义。对于LVEF,在随访12周的亚组(MD = -7.9300, 95% CI: -14.4844 ~ -1.3756)和明显甲状腺功能减退亚组(MD = -7.9300, 95% CI: -14.4844 ~ -1.3756)中发现有统计学意义的增加。L-T4对二尖瓣E和二尖瓣A速度的影响在不同的疾病类型中有显著差异(p=0.0304),在先天性甲状腺功能减退亚组中都有显著增加。E/A比值无显著变化(MD = -0.0058, 95% CI: -0.0360 ~ 0.0244, p=0.7058),亚组间无显著差异。结论:L-T4对超声心动图测量的心功能有不同的影响,具体的改善受随访时间和潜在病因的影响。系统评价注册:https://www.crd.york.ac.uk/PROSPERO/view/, CRD420251274519。
{"title":"Evaluating cardiac echocardiographic changes with levothyroxine in hypothyroid patients: a systematic review and meta-analysis.","authors":"Yanyan Li","doi":"10.3389/fendo.2025.1708811","DOIUrl":"10.3389/fendo.2025.1708811","url":null,"abstract":"<p><strong>Background: </strong>While levothyroxine (L-T4) therapy is standard for hypothyroidism, its direct effects on specific echocardiographic parameters of cardiac function remain underexplored in comprehensive meta-analyses.</p><p><strong>Methods: </strong>We systematically searched multiple databases up to June 2025 for randomized controlled trials and prospective cohort studies assessing L-T4 therapy on echocardiographic parameters in hypothyroid adults. Data on cardiac indices, intervention details, follow-up, and disease types were extracted. Risk of bias was assessed using standard tools. A random-effects model calculated mean differences (MDs) and assessed heterogeneity. Subgroup analyses evaluated treatment type, follow-up duration, and underlying disease.</p><p><strong>Results: </strong>Six studies (2 RCTs and 4 cohort studies) were included. Overall, L-T4 intervention did not significantly alter the LV Tei Index (MD = 0.0214, 95% CI: -0.0294 to 0.0722, p=0.4083) or LVEF (MD = -0.2258, 95% CI: -0.8990 to 0.4475, p=0.5110). However, a statistically significant increase in Mitral E velocity (MD = -0.0646, 95% CI: -0.1138 to -0.0154, p=0.0100) and Mitral A velocity (MD = -0.0646, 95% CI: -0.1138 to -0.0154, p=0.0100) was observed. Subgroup analyses for LV Tei Index showed a statistically significant improvement in the 12-month follow-up subgroup (MD = 0.0672, 95% CI: 0.0161 to 0.1183) and in congenital hypothyroidism (MD = 0.0300, 95% CI: 0.0044 to 0.0556). For LVEF, a statistically significant increase was found in the 12-week follow-up subgroup (MD = -7.9300, 95% CI: -14.4844 to -1.3756) and the overt hypothyroidism subgroup (MD = -7.9300, 95% CI: -14.4844 to -1.3756). The effect of L-T4 on Mitral E and Mitral A velocities varied significantly across disease types (p=0.0304 for both), with a significant increase noted in the congenital hypothyroidism subgroup for both. No significant change was observed in the E/A ratio (MD = -0.0058, 95% CI: -0.0360 to 0.0244, p=0.7058), with no significant subgroup differences.</p><p><strong>Conclusion: </strong>L-T4 exerts differential effects on echocardiographic measures of cardiac function, with specific improvements influenced by follow-up duration and underlying etiology.</p><p><strong>Systematic review registration: </strong>https://www.crd.york.ac.uk/PROSPERO/view/, CRD420251274519.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"16 ","pages":"1708811"},"PeriodicalIF":4.6,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12875953/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146141419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The study on serum oxidized low-density lipoprotein and homocysteine as cardiovascular risk markers in subclinical hypothyroidism patients. 亚临床甲状腺功能减退患者血清氧化低密度脂蛋白和同型半胱氨酸作为心血管危险指标的研究。
IF 4.6 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2026-01-23 eCollection Date: 2026-01-01 DOI: 10.3389/fendo.2026.1750486
Qian Wang, Xiaonyun Zhang, Fan Wu, Xinkun Qi

Purpose: Hypothyroidism, the most prevalent endocrine disorder globally, is associated with increased cardiovascular risk. This study aims to evaluate cardiovascular risk factors-including serum oxidized low-density lipoprotein (ox-LDL), serum homocysteine (Hcy), and lipid profiles-and their correlations with thyroid-stimulating hormone (TSH) levels. Early identification of these risk predictors may reduce the incidence and mortality of cardiovascular disease in hypothyroid patients.

Patients and methods: This cross-sectional study included 676 participants. Subjects were stratified into four groups: three corresponding to TSH quartiles within the reference range and a fourth comprising subclinical hypothyroidism (SCH) patients with TSH levels above this range. All participants underwent physical examinations and provided fasting blood samples for measurement of TSH, free thyroxine (FT4), free triiodothyronine (FT3), blood glucose, triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), apolipoprotein A1 (ApoA1), apolipoprotein B (ApoB), lipoprotein(a) [Lp(a)], ox-LDL, and Hcy.

Results: Across the four subgroups, LDL-C, ApoB, ox-LDL, and Hcy levels exhibited significant increasing trends (all p < 0.05; specific p = 0.01, p = 0.01, p < 0.01, p < 0.01, respectively), whereas HDL-C decreased significantly (p < 0.01). Specifically, compared to the T1 subgroup (TSH: 0.27-1.58 mIU/L), the SCH subgroup (TSH ≥ 4.20 mIU/L) had significantly higher levels of ox-LDL (1.78 ± 0.49 ng/mL vs. 1.05 ± 0.68 ng/mL, p < 0.01) and Hcy (9.87 (interquartile range (IQR): 8.45-11.42) μmol/L vs. 9.22 (IQR: 8.11-10.11) μmol/L, p < 0.01), and lower levels of HDL-C (1.29 ± 0.36 mmol/L vs. 1.43 ± 0.39 mmol/L, p < 0.01). After adjusting for age and sex, TSH levels demonstrated positive correlations with body mass index (BMI), triglycerides, total cholesterol, LDL-C, ApoB, ox-LDL, and Hcy (all p < 0.05), and a negative correlation with HDL-C (p = 0.01). Multiple linear regression analysis revealed that TSH levels were independently associated with elevated ox-LDL (β = 0.18, p < 0.01) and Hcy (β = 0.11, p < 0.01), and reduced HDL-C (β = -0.16, p = 0.01).

Conclusion: The observed correlations between ox-LDL, Hcy, and dyslipidemia in subclinical hypothyroidism may indicate a proatherogenic state. Elevated ox-LDL and Hcy emerge as independent factors associated with accelerated atherosclerosis in this condition.

目的:甲状腺功能减退是全球最常见的内分泌疾病,与心血管风险增加有关。本研究旨在评估心血管危险因素——包括血清氧化低密度脂蛋白(ox-LDL)、血清同型半胱氨酸(Hcy)和脂质谱——及其与促甲状腺激素(TSH)水平的相关性。早期识别这些风险预测因素可以降低甲状腺功能减退患者心血管疾病的发病率和死亡率。患者和方法:这项横断面研究包括676名参与者。受试者被分为四组:三组对应于参考范围内的TSH四分位数,第四组包括TSH水平高于该范围的亚临床甲状腺功能减退(SCH)患者。所有参与者都进行了体检,并提供了空腹血液样本,用于测量TSH、游离甲状腺素(FT4)、游离三碘甲状腺原氨酸(FT3)、血糖、甘油三酯(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、载脂蛋白A1 (ApoA1)、载脂蛋白B (ApoB)、脂蛋白(a) [Lp(a)]、ox-LDL和Hcy。结果:在4个亚组中,LDL-C、ApoB、ox-LDL和Hcy水平均有显著升高的趋势(均p 0.05;特异性p = 0.01, p = 0.01, p 0.01, p 0.01),而HDL-C水平显著降低(p 0.01)。具体而言,与T1亚组(TSH: 0.27 ~ 1.58 mIU/L)相比,SCH亚组(TSH≥4.20 mIU/L)的ox-LDL水平(1.78±0.49 ng/mL vs 1.05±0.68 ng/mL, p 0.01)和Hcy水平(9.87(四分位数间距(IQR): 8.45 ~ 11.42) μmol/L vs 9.22 (IQR: 8.11 ~ 10.11) μmol/L, p 0.01)显著升高,HDL-C水平(1.29±0.36 mmol/L vs 1.43±0.39 mmol/L)显著降低。在调整年龄和性别后,TSH水平与体重指数(BMI)、甘油三酯、总胆固醇、LDL-C、ApoB、ox-LDL和Hcy呈正相关(p均为0.05),与HDL-C呈负相关(p = 0.01)。多元线性回归分析显示,TSH水平与ox-LDL升高(β = 0.18, p 0.01)、Hcy升高(β = 0.11, p 0.01)、HDL-C降低(β = -0.16, p = 0.01)独立相关。结论:观察到亚临床甲状腺功能减退患者ox-LDL、Hcy和血脂异常之间的相关性,提示其可能处于动脉粥样硬化状态。在这种情况下,ox-LDL和Hcy升高是与动脉粥样硬化加速相关的独立因素。
{"title":"The study on serum oxidized low-density lipoprotein and homocysteine as cardiovascular risk markers in subclinical hypothyroidism patients.","authors":"Qian Wang, Xiaonyun Zhang, Fan Wu, Xinkun Qi","doi":"10.3389/fendo.2026.1750486","DOIUrl":"10.3389/fendo.2026.1750486","url":null,"abstract":"<p><strong>Purpose: </strong>Hypothyroidism, the most prevalent endocrine disorder globally, is associated with increased cardiovascular risk. This study aims to evaluate cardiovascular risk factors-including serum oxidized low-density lipoprotein (ox-LDL), serum homocysteine (Hcy), and lipid profiles-and their correlations with thyroid-stimulating hormone (TSH) levels. Early identification of these risk predictors may reduce the incidence and mortality of cardiovascular disease in hypothyroid patients.</p><p><strong>Patients and methods: </strong>This cross-sectional study included 676 participants. Subjects were stratified into four groups: three corresponding to TSH quartiles within the reference range and a fourth comprising subclinical hypothyroidism (SCH) patients with TSH levels above this range. All participants underwent physical examinations and provided fasting blood samples for measurement of TSH, free thyroxine (FT4), free triiodothyronine (FT3), blood glucose, triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), apolipoprotein A1 (ApoA1), apolipoprotein B (ApoB), lipoprotein(a) [Lp(a)], ox-LDL, and Hcy.</p><p><strong>Results: </strong>Across the four subgroups, LDL-C, ApoB, ox-LDL, and Hcy levels exhibited significant increasing trends (all <i>p <</i> 0.05; specific <i>p =</i> 0.01, <i>p =</i> 0.01, <i>p <</i> 0.01, <i>p <</i> 0.01, respectively), whereas HDL-C decreased significantly (<i>p <</i> 0.01). Specifically, compared to the T1 subgroup (TSH: 0.27-1.58 mIU/L), the SCH subgroup (TSH ≥ 4.20 mIU/L) had significantly higher levels of ox-LDL (1.78 ± 0.49 ng/mL vs. 1.05 ± 0.68 ng/mL, <i>p <</i> 0.01) and Hcy (9.87 (interquartile range (IQR): 8.45-11.42) μmol/L vs. 9.22 (IQR: 8.11-10.11) μmol/L, <i>p <</i> 0.01), and lower levels of HDL-C (1.29 ± 0.36 mmol/L vs. 1.43 ± 0.39 mmol/L, <i>p <</i> 0.01). After adjusting for age and sex, TSH levels demonstrated positive correlations with body mass index (BMI), triglycerides, total cholesterol, LDL-C, ApoB, ox-LDL, and Hcy (all <i>p <</i> 0.05), and a negative correlation with HDL-C (<i>p =</i> 0.01). Multiple linear regression analysis revealed that TSH levels were independently associated with elevated ox-LDL (β = 0.18, <i>p <</i> 0.01) and Hcy (β = 0.11, <i>p <</i> 0.01), and reduced HDL-C (β = -0.16, <i>p =</i> 0.01).</p><p><strong>Conclusion: </strong>The observed correlations between ox-LDL, Hcy, and dyslipidemia in subclinical hypothyroidism may indicate a proatherogenic state. Elevated ox-LDL and Hcy emerge as independent factors associated with accelerated atherosclerosis in this condition.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"17 ","pages":"1750486"},"PeriodicalIF":4.6,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12875961/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146141699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Triglyceride-glucose index and periodontitis: evidence from two population-based surveys. 更正:甘油三酯-葡萄糖指数和牙周炎:来自两个基于人群的调查的证据。
IF 4.6 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2026-01-23 eCollection Date: 2026-01-01 DOI: 10.3389/fendo.2026.1775726
Jing Huang, Dan Zhang, Hua Li, Yiyun Zhang, Tianxue Long, Xiaojing Guo, Hangyu Cui, Zixuan Wei, Jun Zhao, Mingzi Li, Pangbo Wang

[This corrects the article DOI: 10.3389/fendo.2025.1558692.].

[这更正了文章DOI: 10.3389/ fend.2025 .1558692.]。
{"title":"Correction: Triglyceride-glucose index and periodontitis: evidence from two population-based surveys.","authors":"Jing Huang, Dan Zhang, Hua Li, Yiyun Zhang, Tianxue Long, Xiaojing Guo, Hangyu Cui, Zixuan Wei, Jun Zhao, Mingzi Li, Pangbo Wang","doi":"10.3389/fendo.2026.1775726","DOIUrl":"https://doi.org/10.3389/fendo.2026.1775726","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.3389/fendo.2025.1558692.].</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"17 ","pages":"1775726"},"PeriodicalIF":4.6,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12879045/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146141478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Frontiers in Endocrinology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1